SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : IMNR - Immune Response -- Ignore unavailable to you. Want to Upgrade?

To: Easy Mark who wrote (292)3/19/1998 2:42:00 PM
From: Manny Gugliuzza  Read Replies (1) | Respond to of 1510
 
that is a good amount with only 4 shots needed. 250,000 cases.
we need to give cats a shot a week for the 1st month then monthly there after with immune regulin.

anyone know the current aids case load in this u s of a??

now we need to get the cost of production and the value of each shot produced and we can see where the .50cents per share estimate is being
drawn from by analysts.

thanks again and i will check with the d.v.m. again for some of this info. i do not feel there should be any limit to that being made available to us.

ar.



To: Easy Mark who wrote (292)3/21/1998 1:42:00 PM
From: Easy Mark  Respond to of 1510
 
Their production facility is definitely capable of 1+ million does annually. Current production cost is about $10 million/year but production volume is only directed at the clinical trials and is thus low.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News